PKM and head and neck squamous cell carcinoma: Moreover, higher expression of MCT4 (HR = 4.55, 95% CI: 2.24-9.23, P < 0.001), and PKM2 (HR = 2.53, 95% CI: 1.01-6.37, P = 0.008) correlated with worse DFS in HNSCC patients.